Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07603050
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's DiseaseShanghai Vitalgen BioPharma Co., Ltd.Not Yet RecruitingPhase 1
NCT07603050Not Yet Recruiting
Phase 1
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in P...Shanghai Vitalgen BioPhar...
NCT07604480
Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Prospective Observational StudyUniversity of Medicine and Pharmacy "Victor Babes" TimisoaraCompleted
NCT07604480Completed
—
Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Pros...University of Medicine an...
NCT07602361
Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweight and ObesityUniversidad Autonoma de Baja CaliforniaActive Not RecruitingNot Applicable
NCT07602361Active Not Recruiting
Not Applicable
Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweig...Universidad Autonoma de B...
NCT07604610
Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian PopulationsNational Medical Research Center for Therapy and Preventive MedicineRecruiting
NCT07604610Recruiting
—
Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian PopulationsNational Medical Research...
NCT07600775
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 1
NCT07600775Not Yet Recruiting
Phase 1
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuber...Merck Sharp & Dohme LLC
NCT07604142
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant PlacementTanta UniversityEnrolling By InvitationNot Applicable
NCT07604142Enrolling By Invitation
Not Applicable
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant...Tanta University
NCT07602426
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of resO™ Bone and Joint Support Postbiotic on Physical Function, Pain Interference, and Mobility in Adults With Joint DiscomfortAble Biolabs, LLCActive Not RecruitingNot Applicable
NCT07602426Active Not Recruiting
Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of...Able Biolabs, LLC
NCT07600866
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan CohortNucleo Research, Inc.Not Yet Recruiting
NCT07600866Not Yet Recruiting
—
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Sc...Nucleo Research, Inc.
NCT07600853
Development and Validation of an E-learning Module on Systemic Anticancer Therapy and Its Effectiveness on the Knowledge Attitude and Practice of Nurses in Administering Systemic Anticancer Agents at a Specialized Cancer Centres in Oman.Sultan Qaboos Comprehensive Cancer CenterNot Yet RecruitingNot Applicable
NCT07600853Not Yet Recruiting
Not Applicable
Development and Validation of an E-learning Module on Systemic Anticancer Therap...Sultan Qaboos Comprehensi...
NCT07602530
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical PracticeAstellas Pharma Europe Ltd.Recruiting
NCT07602530Recruiting
—
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezoline...Astellas Pharma Europe Lt...
NCT07603765
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - CerrahpasaRecruiting
NCT07603765Recruiting
—
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - Cer...
NCT07604363
High-Fidelity Simulation and Longitudinal Outcomes in Novice Nurses (HFS-NOVA)Tri-Service General HospitalCompletedNot Applicable
NCT07604363Completed
Not Applicable
High-Fidelity Simulation and Longitudinal Outcomes in Novice Nurses (HFS-NOVA)Tri-Service General Hospi...
NCT07601282
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction SurgeryShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruiting
NCT07601282Recruiting
—
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary...Shanghai General Hospital...
NCT07601165
Soft Tissue Release for Elbow Pronation in Cerebral PalsyIstanbul University - CerrahpasaNot Yet RecruitingNot Applicable
NCT07601165Not Yet Recruiting
Not Applicable
Soft Tissue Release for Elbow Pronation in Cerebral PalsyIstanbul University - Cer...
NCT07602699
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Drug Abuse (NIDA)RecruitingPhase 2
NCT07602699Recruiting
Phase 2
Multi-Site Trial of Tirzepatide for Smoking CessationNational Institute on Dru...
NCT07604623
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac SurgeryUniversity of AlbertaNot Yet RecruitingNot Applicable
NCT07604623Not Yet Recruiting
Not Applicable
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Ca...University of Alberta
NCT07601737
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell CarcinomaShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruitingPhase 2
NCT07601737Recruiting
Phase 2
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of L...Shanghai General Hospital...
NCT07602881
Blood Exosomal Multi-omics and Lung Radiomics for Predicting Efficacy and Prognosis of Severe Eosinophilic ACOS With BiologicsUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNot Yet Recruiting
NCT07602881Not Yet Recruiting
—
Blood Exosomal Multi-omics and Lung Radiomics for Predicting Efficacy and Progno...Union Hospital, Tongji Me...
Result Breakdown
Not yet recruiting8 (40%)
Recruiting6 (30%)
Completed3 (15%)
Active, not recruiting2 (10%)
Enrolling by invitation1 (5%)
Not Specified8 (40%)
not_applicable8 (40%)
Phase 12 (10%)
Phase 22 (10%)